Inhibition of TNF-alpha-induced activation of NF-kappaB by hantavirus nucleocapsid proteins

Ann N Y Acad Sci. 2009 Sep:1171 Suppl 1:E86-93. doi: 10.1111/j.1749-6632.2009.05049.x.

Abstract

Hantaviruses cause two human diseases thought to be immune-mediated: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). We recently reported that the nucleocapsid (N) protein of HFRS-causing Hantaan virus (HTNV) inhibits tumor necrosis factor-alpha (TNF-alpha) activation of nuclear factor-kappaB (NF-kappaB). Here we measured the ability of other hantaviral N proteins to similarly interfere with the inflammatory process of TNF-alpha. We found that like HTNV N, the N proteins of HFRS-causing Seoul and Dobrava viruses inhibited TNF-alpha activation of NF-kappaB and translocation of the NF-kappaB p65 subunit, but did not interfere with degradation of inhibitor of NF-kappaB (IkappaB). In contrast, the HFRS-causing Puumala virus and the HPS-causing Andes and Sin Nombre viruses did not prevent TNF-alpha activation of NF-kappaB or nuclear translocation of p65. These studies provide evidence that hantaviruses differ in their abilities to interfere with host innate immune responses.

MeSH terms

  • Asia / epidemiology
  • Cell Line
  • Europe / epidemiology
  • Genes, Reporter
  • Genome, Viral
  • Geography
  • Green Fluorescent Proteins / genetics
  • Hantavirus Pulmonary Syndrome / epidemiology
  • Hantavirus Pulmonary Syndrome / virology
  • Hemorrhagic Fever with Renal Syndrome / epidemiology
  • Hemorrhagic Fever with Renal Syndrome / virology*
  • Humans
  • Kidney / embryology
  • Kidney / virology
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / genetics
  • Nucleocapsid Proteins / pharmacology*
  • Orthohantavirus / genetics
  • Orthohantavirus / metabolism*
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • NF-kappa B
  • Nucleocapsid Proteins
  • Tumor Necrosis Factor-alpha
  • Green Fluorescent Proteins